Skip to main content
logo
SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
21.62
+0.80 (3.84%)
Jul 28, 2026, 4:00 PM EDT - Market closed

SpyGlass Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
238.996.3616.2715.85
Short-Term Investments
12.111.08-24.47
Cash & Short-Term Investments
251107.4416.2740.32
Cash Growth
1442.92%560.41%-59.65%-
Other Receivables
0.650.430.420.12
Total Trade Receivables
0.650.430.420.12
Other Current Assets
1.710.90.720.18
Total Current Assets
253.36108.7717.4140.61
Net Property, Plant & Equipment
4.243.895.460.45
Other Long-Term Assets
0.793.210.450.09
Total Assets
258.39115.8723.3241.15

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Accounts Payable
3.512.71.980.64
Accrued Expenses
0.882.181.280.61
Current Portion of Leases
--0.44-
Other Current Liabilities
2.273.714.090.34
Total Current Liabilities
6.678.587.791.59
Long-Term Leases
1.611.583.46-
Total Long-Term Liabilities
1.611.583.46-
Total Liabilities
8.2710.1711.251.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Common Stock
---0
Additional Paid-in Capital
368.665.894.392.71
Retained Earnings
-118.55-104.73-64.86-35.7
Total Common Shareholders' Equity
250.11-98.84-60.47-32.99
Minority Interest
---72.55
Shareholders' Equity
250.11-98.84-60.4739.56
Total Liabilities & Equity
258.39115.8723.3241.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Total Debt
1.611.583.90
Net Cash (Debt)
249.4105.8512.3740.32
Net Cash Growth
1915.96%755.66%-69.31%-
Net Cash Per Share
7.4647.746.9223.20
Book Value
250.11-98.84-60.47-32.99
Book Value Per Share
7.48-44.58-33.82-18.98
Tangible Book Value
250.11-98.84-60.47-32.99
Tangible Book Value Per Share
7.48-44.58-33.82-18.98
SEC Filings: 10-K · 10-Q